Trial Profile
A phase I/II study of aroplatin [L NDDP] and gemcitabine in subjects with unresectable, locally advanced and/or metastatic pancreatic cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 24 Sep 2005
Price :
$35
*
At a glance
- Drugs L NDDP (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.